RS
FBIO icon

R Squared’s Fortress Biotech FBIO Stock Holding History

R Squared’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-10,171
Closed -$18.9K – 607
2025
Q2 		$18.9K Buy
+10,171
New +$17.6K 0.01% 443
2025
Q1 		– Sell
-1,380
Closed -$2.79K – 687
2024
Q4 		$2.79K Buy
+1,380
New +$2.5K ﹤0.01% 1422

Other funds holding FBIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
SC
Sculptor Capital New York $12.3B AUM 40.26% 1-Year Est. Return
KAS
Kestra Advisory Services Austin, Texas $31B AUM 28.39% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HWM
HB Wealth Management Atlanta, Georgia $17.8B AUM 24.16% 1-Year Est. Return

R Squared's FBIO Position: Q3 2025 in Review

R Squared sold out of Fortress Biotech (FBIO) in Q3 2025, closing a stake of 10,171 shares — an estimated $18.9K sold.

R Squared first reported a position in FBIO in Q4 2024 and held it in 2 quarters. The position peaked at $18.9K in Q2 2025. 56 funds tracked by Wall St. Rank hold FBIO as of Q3 2025.

  • R Squared reported no remaining Fortress Biotech position as of Q3 2025 after selling out during the quarter.
  • R Squared sold 10,171 Fortress Biotech shares in Q3 2025, an estimated $18.9K.
  • R Squared first reported a position in Fortress Biotech in Q4 2024 and held it in 2 quarters.
  • R Squared's Fortress Biotech position peaked at $18.9K in Q2 2025.
  • 56 funds tracked by Wall St. Rank held Fortress Biotech as of Q3 2025.

Based on R Squared's 13F filing for Q3 2025, filed 12 Nov 2025.